Skip to Main Content

Author Details

Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
2006
151
40
PMIDPaper TitleJournal TitlePublished Year
36865297Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients.medRxiv2023
37828555Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine.Genome Med2023
36950216Early-onset grade 2-3 diffuse gliomas and schwannomas increase the risk of central nervous system tumors among the patients' relatives.Neurooncol Adv2023
37017776Spatial cumulant models enable spatially informed treatment strategies and analysis of local interactions in cancer systems.J Math Biol2023
37015057FURIN regulates cytotoxic T-lymphocyte effector function and memory cell transition in mice.Eur J Immunol2023
37140987Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases.Endocr Relat Cancer2023
36858798RAS and PP2A activities converge on epigenetic gene regulation.Life Sci Alliance2023
36622851Characterization of the innate immune response to Streptococcus pneumoniae infection in zebrafish.PLoS Genet2023
35128089Spatial analysis of histology in 3D: quantification and visualization of organ and tumor level tissue environment.Heliyon2022
35697807Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.Nat Biotechnol2022
35859180Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer.Nature2022
35748858The transcription factor network of E. coli steers global responses to shifts in RNAP concentration.Nucleic Acids Res2022
35931748Functional human cell-based vascularised cardiac tissue model for biomedical research and testing.Sci Rep2022
35982066PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas.Sci Rep2022
36219867Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen.Endocr Relat Cancer2022
35318951Novel ZNF414 activity characterized by integrative analysis of ChIP-exo, ATAC-seq and RNA-seq data.Biochim Biophys Acta Gene Regul Mech2022
33420073Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer.Nat Commun2021
33925994Gene Regulation Network Analysis on Human Prostate Orthografts Highlights a Potential Role for the <i>JMJD6</i> Regulon in Clinical Prostate Cancer.Cancers (Basel)2021
33930428Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer.Gastroenterology2021
33836265Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial.Ann Oncol2021
34489465Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse.Nat Commun2021
34348967Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity.Cancer Res2021
33986188CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity.JCI Insight2021
34174143Proprotein convertase subtilisin/kexin type 9 regulates the production of acute-phase reactants from the liver.Liver Int2021
34337548Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine.Eur Urol Open Sci2021
34283056Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response.Cancers (Basel)2021
34083234Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition.Clin Cancer Res2021
33446885Independent and cumulative coeliac disease-susceptibility loci are associated with distinct disease phenotypes.J Hum Genet2021
31398111Cytokeratin-Supervised Deep Learning for Automatic Recognition of Epithelial Cells in Breast Cancers Stained for ER, PR, and Ki-67.IEEE Trans Med Imaging2020
31744911Metagenomics of the faecal virome indicate a cumulative effect of enterovirus and gluten amount on the risk of coeliac disease autoimmunity in genetically at risk children: the TEDDY study.Gut2020
31660579Moderate-to-strong expression of FGFR3 and TP53 alterations in a subpopulation of choroid plexus tumors.Histol Histopathol2020
33033260Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy.Nat Commun2020
32931743Immunogenomic Landscape of Hematological Malignancies.Cancer Cell2020
32555329AR and ERG drive the expression of prostate cancer specific long noncoding RNAs.Oncogene2020
32390293Prostate-specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain.J Cell Mol Med2020
32183364Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer.Genes (Basel)2020
32451180Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer.Eur Urol2020
31626817Characterization of immune response against Mycobacterium marinum infection in the main hematopoietic organ of adult zebrafish (Danio rerio).Dev Comp Immunol2020
30638634Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.Eur Urol2019
32914020Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer.JCO Precis Oncol2019
29945183Essential Physiological Differences Characterize Short- and Long-Lived Strains of Drosophila melanogaster.J Gerontol A Biol Sci Med Sci2019
31329928Data-driven characterization of molecular phenotypes across heterogeneous sample collections.Nucleic Acids Res2019
31522136Supervised pathway analysis of blood gene expression profiles in Alzheimer's disease.Neurobiol Aging2019
31444413Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma.Oncogene2019
30837492Extensive reprogramming of the nascent transcriptome during iPSC to hepatocyte differentiation.Sci Rep2019
31092619Editor's Note: Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment.Clin Cancer Res2019
30940663Hemap: An Interactive Online Resource for Characterizing Molecular Phenotypes across Hematologic Malignancies.Cancer Res2019
30847018Modes of immunosuppression in glioblastoma microenvironment.Oncotarget2019
28918083Topical fluorometholone treatment and desiccating stress change inflammatory protein expression in tears.Ocul Surf2018
30129002Bioinformatics Assembling and Assessment of Novel Coxsackievirus B1 Genome.Methods Mol Biol2018
  • 1 - 50 of 151

Recommended Authors

Elana J Fertig
Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 4
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 15
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 5
Xiaotu Ma
St. Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 2
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 5
Chao Cheng
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 5
Adam A Margolin
Icahn School of Medicine
Career Start Year 2004
Number of shared co-authors 6
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 8
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 26
Florian Markowetz
CRUK Cambridge Institute, University of Cambridge
Career Start Year 2003
Number of shared co-authors 3
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 5
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 2
Amy G Robertson
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 20
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 21
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 19
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 19
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 0
Ludmila Danilova
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year 2001
Number of shared co-authors 3
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 30
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 6
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 1
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 17
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 16
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 59
Andrea Califano
Columbia University
Career Start Year 1993
Number of shared co-authors 12
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 4
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 1
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 10
Pablo Tamayo
University of California San Diego
Career Start Year 1988
Number of shared co-authors 3
Yuval Kluger
Yale University School of Medicine
Career Start Year 1984
Number of shared co-authors 1

Collaborators

Matti Annala
University of British Columbia
Co-authored papers 41
Tapio Visakorpi
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 34
Ilya Shmulevich
Institute for Systems Biology
Co-authored papers 17
Sinja Taavitsainen
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 15
Pekka Ruusuvuori
Institute of Biomedicine, University of Turku
Co-authored papers 15
Leena Latonen
Foundation for the Finnish Cancer Institute
Co-authored papers 14
Kim N Chi
University of British Columbia
Co-authored papers 13
Alexander W Wyatt
University of British Columbia
Co-authored papers 13
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 12
Wei Zhang
The University of Texas MD Anderson Cancer Center
Co-authored papers 12
Wei Zhang
University of Manchester
Co-authored papers 11
David Cogdell
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 8
Alfonso Urbanucci
Northwestern University Feinberg School of Medicine Chicago
Co-authored papers 8
Martin E Gleave
University of British Columbia
Co-authored papers 8
Gregory N Fuller
MD Anderson Cancer Center
Co-authored papers 6
Kimmo Kartasalo
Karolinska Institutet
Co-authored papers 5
Limei Hu
Aier Eye Hospital of Wuhan University
Co-authored papers 5
Jilong Yang
Tianjin Medical University Cancer Institute and Hospital
Co-authored papers 5
Elie Ritch
University of British Columbia
Co-authored papers 5
Mira Valkonen
Tampere University
Co-authored papers 5
Jonathan C Trent
Sylvester Comprehensive Cancer Center, University of Miami
Co-authored papers 4
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 4
Cameron Herberts
University of British Columbia
Co-authored papers 4
Johanna Schleutker
Institute of Biomedicine, University of Turku
Co-authored papers 4
Raphael E Pollock
James Cancer Center, The Ohio State University
Co-authored papers 3
Peter Van Loo
The Francis Crick Institute
Co-authored papers 3
Nathan D Price
Institute for Systems Biology
Co-authored papers 3
Eric J Small
University of California san francisco
Co-authored papers 3
Arun A Azad
Peter MacCallum Cancer Centre
Co-authored papers 3
Release 1.2